• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Studies on 3-diethylaminocarbonyl-1,4,5,6,7,8-hexahydroquinoline derivatives and their calcium channel antagonistic activities in vitro.

作者信息

Kismetli Emrah, Safak Cihat, Erol Kevser, Sirmagül Başar, Linden Anthony

机构信息

Hacettepe University, Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Ankara, Turkey.

出版信息

Arzneimittelforschung. 2004;54(7):371-5.

PMID:15344840
Abstract

In this study, thirteen 2,6,6-trimethyl-3-carbamoyl-4-aryl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives were synthesized and screened for their calcium channel antagonistic actitivities. The hexahydroquinoline derivatives were synthesized according to Hantzsch reaction. The structures of the compounds were elucidated by IR, 1H-NMR, 13C-NMR, Distortionless Enhancement Polarization Transfer (DEPT), Correlation Spectroscopy (COSY), mass spectroscopy and elemental analyses. The calcium antagonistic activities of the compounds were determined by tests performed on isolated rat ileum and lamb carotid artery. In isolated rat ileum, compounds 8, 12 and 13 were found to be more active than nicardipine (CAS 55985-32-5) at a concentration of 10(-5) mol/L. At the concentration 10(-4) mol/L, compounds 7 and 12 were more active than nicardipine and compounds 5, 8 and 13 were equipotent. In lamb carotid artery studies, at the concentration 10(-5) mol/L all compounds were found to be less active than nicardipine; at the concentration 10(-4) mol/L compounds 5 and 13 showed greater inhibition than nicardipine. At this concentration, compound 9 was found to be as active as nicardipine.

摘要

相似文献

1
Studies on 3-diethylaminocarbonyl-1,4,5,6,7,8-hexahydroquinoline derivatives and their calcium channel antagonistic activities in vitro.
Arzneimittelforschung. 2004;54(7):371-5.
2
Synthesis, evaluation of the calcium antagonistic activity and biotransformation of hexahydroquinoline and furoquinoline derivatives.六氢喹啉和呋喃喹啉衍生物的合成、钙拮抗活性评估及生物转化
Arzneimittelforschung. 2003;53(3):159-66.
3
Studies on calcium modulatory activities of 2,6,6-trimethyl-3-acetyl-4-aryl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives.
Arzneimittelforschung. 1999 Oct;49(10):824-9. doi: 10.1055/s-0031-1300509.
4
Studies on calcium antagonist activities of 2-ethyl-3-carbmethoxy-4-aryl- 5-oxo-6,6-dimethyl-1,4,5,6,7,8-hexahydroquinoline derivatives.
Arzneimittelforschung. 2001;51(12):959-63. doi: 10.1055/s-0031-1300145.
5
Studies on the synthesis and biological activitiy of 6-ethyl-4-aryl-5-methoxycarbonyl-3,4-dihydropyrimidin-2(1H)-ones.6-乙基-4-芳基-5-甲氧基羰基-3,4-二氢嘧啶-2(1H)-酮的合成与生物活性研究
Arzneimittelforschung. 2007;57(3):137-42. doi: 10.1055/s-0031-1296596.
6
Synthesis, enantioseparation and pharmacological activity of 4-aryl-7,7-dimethyl-5-oxo-1,2,3,4,5,6,7,8-octahydroquinazoline-2-thiones.
Arzneimittelforschung. 2002;52(1):27-33. doi: 10.1055/s-0031-1299852.
7
4-difluoro-substituted phenl-5-oxohexahydroquinoline derivatives and their effects on calcium channels.
Arzneimittelforschung. 2006;56(7):529-34.
8
3-Acetyl-4-aryl-5-oxo-2,7,7-trimethyl-1,4,5,6,7,8-hexahydro-quinoline derivatives and their calcium antagonistic activities.
Arzneimittelforschung. 1995 Nov;45(11):1154-6.
9
Studies on condensed 1,4-dihydropyridine derivatives and their calcium modulatory activities.稠合1,4 - 二氢吡啶衍生物及其钙调节活性的研究。
Pharmazie. 2006 Aug;61(8):655-9.
10
Synthesis of hexahydroquinoline derivatives possessing calcium antagonistic activity.
Pharmazie. 2001 Aug;56(8):665-6.

引用本文的文献

1
5-Oxo-hexahydroquinoline: an attractive scaffold with diverse biological activities.5-氧代己基六氢喹啉:一种具有多种生物活性的有吸引力的支架。
Mol Divers. 2019 May;23(2):471-508. doi: 10.1007/s11030-018-9886-4. Epub 2018 Nov 2.